Michael Lee Brooks, insider at Syneos Health

Michael Lee Brooks Insider Information

Insider of Syneos Health
Leads the global Clinical Development organization encompassing clinical pharmacology services, full service clinical trial and product development capabilities, scientific and therapeutic expertise, FSP and hybrid models, and digital and mobile health solutions

Responsible for ensuring a product development mindset throughout the organization; Focused on maximizing the return on investments for customers, providing an exceptional customer experience and achieving growth targets; Implements innovative solutions through integrated Syneos Health commercial capabilities, patient and healthcare professional insights and digital engagement

25+ years of clinical development and commercialization experience; strong track record of transforming business units and companies, setting strategy and spearheading high-value solutions across the product development lifecycle

Brings extensive global product development experience to Syneos Health from prior roles, including serving as President & Global Head at LabCorp (Covance) Clinical Development & Commercialization Services and Executive Vice President & Global Head of Clinical Development at PRA Health Sciences encompassing work across phase I-IV, FSP, clinical pharmacology/phase I units, real-world outcomes/post marketing, consulting, commercial services and global service delivery hubs in China and India

Bachelor of Science, North Carolina State University; Member, College of Sciences Foundation Board of Directors, North Carolina State University

What is Michael Lee Brooks' net worth?

The estimated net worth of Michael Lee Brooks is at least $3.28 million as of July 28th, 2022. Mr. Brooks owns 47,552 shares of Syneos Health stock worth more than $3,277,759 as of August 17th. This net worth evaluation does not reflect any other assets that Mr. Brooks may own. Additionally, Mr. Brooks receives a salary of $771,470.00 as Insider at Syneos Health. Learn More about Michael Lee Brooks' net worth.

How old is Michael Lee Brooks?

Mr. Brooks is currently 48 years old. There are 6 older executives and no younger executives at Syneos Health. The oldest executive at Syneos Health is Ms. Michelle Keefe, CEO & Director, who is 55 years old. Learn More on Michael Lee Brooks' age.

What is Michael Lee Brooks' salary?

As the Insider of Syneos Health, Inc., Mr. Brooks earns $771,470.00 per year. The highest earning executive at Syneos Health is Mr. Alistair Macdonald, Advisor, who commands a salary of $1,250,000.00 per year. Learn More on Michael Lee Brooks' salary.

How do I contact Michael Lee Brooks?

The corporate mailing address for Mr. Brooks and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected] Learn More on Michael Lee Brooks' contact information.

Has Michael Lee Brooks been buying or selling shares of Syneos Health?

Within the last three months, Michael Lee Brooks has sold $228,456.00 of Syneos Health stock. Most recently, Michael Lee Brooks sold 1,002 shares of the business's stock in a transaction on Thursday, July 28th. The shares were sold at an average price of $78.00, for a transaction totalling $78,156.00. Following the completion of the sale, the chief operating officer now directly owns 47,552 shares of the company's stock, valued at $3,709,056. Learn More on Michael Lee Brooks' trading history.

Who are Syneos Health's active insiders?

Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

Are insiders buying or selling shares of Syneos Health?

During the last twelve months, insiders at the sold shares 14 times. They sold a total of 39,033 shares worth more than $3,240,651.96. The most recent insider tranaction occured on July, 28th when COO Michael Lee Brooks sold 1,002 shares worth more than $78,156.00. Insiders at Syneos Health own 0.3 % of the company. Learn More about insider trades at Syneos Health.

Information on this page was last updated on 7/28/2022.

Michael Lee Brooks Insider Trading History at Syneos Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/28/2022Sell1,002$78.00$78,156.0047,552View SEC Filing Icon  
7/21/2022Sell1,002$76.00$76,152.0048,554View SEC Filing Icon  
7/19/2022Sell1,002$74.00$74,148.0049,556View SEC Filing Icon  
12/22/2021Sell93$99.00$9,207.00View SEC Filing Icon  
See Full Table

Michael Lee Brooks Buying and Selling Activity at Syneos Health

This chart shows Michael Lee Brooks's buying and selling at Syneos Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Syneos Health Company Overview

Syneos Health logo
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.
Read More

Today's Range

Now: $68.93
Low: $68.49
High: $69.60

50 Day Range

MA: $70.95
Low: $63.06
High: $79.14

2 Week Range

Now: $68.93
Low: $62.28
High: $104.18

Volume

416,664 shs

Average Volume

756,654 shs

Market Capitalization

$7.08 billion

P/E Ratio

25.91

Dividend Yield

N/A

Beta

1.68